Est. 2026 · Laredo, Texas · USA

Chronic disease care, rebuilt for Africa.

Ọ̀gàńláHealth LLC is a US-incorporated parent company building a vertically integrated platform for chronic disease management across Sub-Saharan Africa — beginning with continuous glucose monitoring through our medical device subsidiary, with compounded therapeutics to follow.

Join the waitlist → Explore our companies

Parent

Ọ̀gàńláHealth LLC
US-registered medical holding company

Target Markets

Rwanda · Ghana · Nigeria
US diaspora (post FDA 510(k))

Founded By

Dr. Kehinde Busari, PharmD
Clinician-led, US-licensed

01 — The Numbers

The chronic disease crisis nobody is building for.

Diabetes is rising faster in Africa than in any region on Earth. The infrastructure to treat it has not followed. We are building that infrastructure.

24M+

Africans currently living with diabetes — projected to reach 55 million by 2045.

<3%

Of African diabetics have access to continuous glucose monitoring, the standard of care in the West.

134%

Projected increase in diabetes-related deaths in Sub-Saharan Africa by 2045 — the fastest rise globally.

Sources: International Diabetes Federation, Diabetes Atlas (10th Edition); WHO Africa Regional Office, NCD Reports.

02 — Structure

Two companies. One mission.

Ọ̀gàńláHealth operates as a holding company with two focused subsidiaries — each addressing a different layer of the chronic disease care stack. Devices generate the patient relationship. Medications deepen it.

Active · Launching 2026

Ọ̀gàńláHealth Devices

A locally-registered continuous glucose monitor designed for the climate, lives, and clinical realities of African markets — supported by integrated telemedicine.

Product 14–16 day inserted CGM sensor with NFC scan via smartphone

Regulatory In submission — Rwanda FDA, Ghana FDA, Nigeria NAFDAC

Operations Subsidiaries registered in Tema Free Zone (Ghana) and Lekki Medical SEZ (Nigeria)

Support Faraheal telemedicine integration · WhatsApp clinical support

Pipeline · 2027 onward

Ọ̀gàńláHealth Medications

Compounded therapeutics for diabetes and adjacent chronic conditions — extending the patient relationship beyond monitoring into ongoing pharmacological care.

Categories Diabetes management, GLP-1 analogues, BHRT, men's health

Backbone Healthville Pharmacy — licensed 503A sterile and non-sterile compounding (5 US states)

Approach CGM-prescribed therapeutics — closed-loop care for African patients

Timeline Product roadmap and regulatory pathway under development

03 — Leadership

Built by clinicians, for African patients.

Ọ̀gàńláHealth was founded by Dr. Kehinde Busari, PharmD — a US-licensed clinical pharmacist with a track record of building healthcare infrastructure across pharmacy, telemedicine, and clinical compounding.

Most medical device companies entering African markets are led by financiers, technologists, or international subsidiaries with limited clinical roots. Ọ̀gàńláHealth is different. We are built by a working clinician, with operational businesses already serving patients today, and a clear understanding that medical devices succeed or fail based on whether real doctors trust them and real patients can use them.

Our founding team has built and operates Healthville Pharmacy, a licensed 503A compounding pharmacy serving approximately 500 active patients, and Faraheal, a telemedicine platform operating across five US states. Ọ̀gàńláHealth is the natural next chapter — bringing that operational rigor to chronic disease care in the markets that need it most.

Headquarters

Laredo, Texas, USA

Subsidiaries

Ọ̀gàńláHealth Devices Ghana Ltd
Ọ̀gàńláHealth Devices Nigeria Ltd

Founding Team

Dr. Kehinde Busari, PharmD
Founder & Chief Executive

Related Operations

Healthville Pharmacy · Faraheal Telemedicine

04 — Be First

Be first when the Ọ̀gàńláCGM launches in your country.

Join the waitlist to receive launch updates, regulatory milestones, and early-access pricing for Ọ̀gàńláHealth Devices' first product. Patients, healthcare providers, distributors, and investors are all welcome.

We respect your privacy. Your email is used solely for Ọ̀gàńláHealth product updates and is never shared or sold. Unsubscribe at any time.

You're on the list.

Thank you for joining. We'll be in touch as soon as we have regulatory milestones and launch dates to share.